Sunshine Biopharma, Inc. ( SBFM) - Key Metrics
SBFM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $41.86 | -$7.88 | -$5.66 | -$8.11 |
| 2025Q1 | $3.29 | -$0.44 | -$0.63 | -$0.71 |
| 2024Q4 | $3.72 | -$0.84 | -$1.32 | -$1.49 |
| 2024Q3 | $6.65 | -$0.94 | -$1.07 | -$1.48 |
SBFM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -0.05 |
| 2025Q1 | ? | -1.09 |
| 2024Q4 | ? | -0.90 |
| 2024Q3 | ? | -0.84 |
SBFM
Price: $2.69
52 week price:
Earnings Per Share: -15.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 5.4 million